Dispersion for pulmonary delivery of a bioactive agent
View Patent ↗Stabilized dispersions are provided for the delivery of a bioactive agent. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a liquid fluorochemical. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as by settling or flocculation. In particularly preferred embodiments the stabilized dispersions may be directly administered to the lung of a patient using an endotracheal tube or bronchoscope.
1. A dispersion for the pulmonary delivery of a bioactive agent to a patient, the dispersion comprising:
(a) a plurality of permeable microstructures, the permeable microstructures comprising at least one bioactive agent, and
(b) a suspension medium that permeates into the permeable microstructures.
2. A dispersion according to claim 1 wherein the permeable microstructures comprise at least one of a phospholipid, nonionic detergent, nonionic block copolymer, ionic surfactant, biocompatible fluorinated surfactant or combinations thereof.
3. A dispersion according to claim 1 wherein the permeable microstructures comprise a phospholipid.
4. A dispersion according to claim 3 wherein the phospholipid is a saturated phospholipid.
5. A dispersion according to claim 3 wherein the permeable microstructures comprise an inorganic salt.
6. A dispersion according to claim 5 wherein the inorganic salt comprises calcium chloride.
7. A dispersion according to claim 5 wherein the gel to liquid transition temperature of the permeable microstructures is greater than 40° C.
8. A dispersion according to claim 1 wherein the permeable microstructures and suspension medium have a refractive index differential of less than 0.5.
9. A dispersion according to claim 1 wherein the permeable microstructures have a mean density selected to provide a density differential with that of the suspension medium of less than 0.6 g/cm 3 .
10. A dispersion according to claim 1 wherein the suspension medium comprises a fluorochemical.
11. A dispersion according to claim 1 wherein the bioactive agent comprises one or more of antiallergics, bronchodilators, pulmonary lung surfactants, analgesics, antibiotics, leukotriene inhibitors or antagonists, antihistamines, anti-inflammatories, antineoplastics, anticholinergics, anesthetics, anti-tuberculars, imaging agents, cardiovascular agents, enzymes, steroids, genetic material, viral vectors, antisense agents, proteins, peptides or combinations thereof.
12. A dispersion according to claim 1 wherein the bioactive agent is gentamicin.
13. A dispersion according to claim 1 wherein the permeable microstructures have a mean diameter of 1-30 μm.
14. A dispersion for the pulmonary delivery of a bioactive agent to a patient, the dispersion comprising:
(a) a plurality of permeable microstructures, the permeable microstructures comprising at least one of a phospholipid, nonionic detergent, nonionic block copolymer, ionic surfactant, biocompatible fluorinated surfactant or combinations thereof;
(b) at least one bioactive agent; and
(c) a suspension medium that permeates into the permeable microstructures.
15. A dispersion according to claim 14 wherein the permeable microstructures comprise a phospholipid.
16. A dispersion according to claim 15 wherein the phospholipid is a saturated phospholipid.
17. A dispersion according to claim 14 wherein the permeable microstructures comprise an inorganic salt.
18. A dispersion according to claim 17 wherein the inorganic salt comprises calcium chloride.
19. A dispersion according to claim 17 wherein the gel to liquid transition temperature of the permeable microstructures is greater than 40° C.
20. A dispersion according to claim 17 wherein the permeable microstructures and suspension medium have at least one of:
(1) a refractive index differential of less than 0.5; or
(2) a density differential of less than 0.6 g/cm 3 .
21. A dispersion according to claim 14 wherein the bioactive agent comprises one or more of antiallergics, bronchodilators, pulmonary lung surfactants, analgesics, antibiotics, leukotriene inhibitors or antagonists, antihistamines, anti-inflammatories, antineoplastics, anticholinergics, anesthetics, anti-tuberculars, imaging agents, cardiovascular agents, enzymes, steroids, genetic material, viral vectors, antisense agents, proteins, peptides or combinations thereof.